Human Mesenchymal Stem Cell Culture
This product consists of human mesenchymal stem cells cultured in a nutrient medium for therapeutic applications in regenerative medicine, such as treating joint injuries or autoimmune diseases. It falls under HTS 3002.59.00.00 as 'other cell cultures, whether or not modified,' prepared for therapeutic uses via biotechnological processes. These cultures are not yeasts and are used directly in patient treatments.
Import Duty Rates by Country of Origin
| Origin Country | MFN Rate | Ch.99 Surcharges | Total Effective Rate |
|---|---|---|---|
| 🇨🇳China | Free | — | Free |
| 🇲🇽Mexico | Free | — | Free |
| 🇨🇦Canada | Free | — | Free |
| 🇩🇪Germany | Free | — | Free |
| 🇯🇵Japan | Free | — | Free |
Alternative Classifications
This product could be classified differently depending on its characteristics or intended use.
If derived from human blood rather than independent cell culture
Cell cultures originating directly from blood processing fall under antisera and blood fractions in 3002.12
If for strictly laboratory research, not therapeutic use
Diagnostic or research reagents of biological origin go to Chapter 38 if not for clinical/therapeutic purposes
If including yeasts or not purely cell cultures
Cultures of micro-organisms (excluding yeasts) or similar products shift to other subheadings
Not sure which classification is right?
Our AI classifier can analyze your specific product and recommend the correct HTS code with confidence.
Import Tips & Compliance
• Obtain FDA approval and biologics license; ensure cold chain documentation for viability during transport
• Provide certificates of analysis confirming cell type, purity, and absence of contaminants like mycoplasma
• Avoid misclassification as research reagents; verify therapeutic intent to prevent duty disputes
Related Products under HTS 3002.59.00.00
Human Neural Progenitor Cell Culture
Progenitor cells from human neural tissue expanded in culture for neurodegenerative disease therapies like Parkinson's. Classified in HTS 3002.59.00.00 as other cell cultures modified biotechnologically for therapeutic uses. Used in stem cell transplants.
Human Keratinocyte Cell Culture
Epidermal keratinocytes cultured for skin graft therapies in burn treatment and wound healing. Falls under HTS 3002.59.00.00 as other human cell cultures for therapeutic uses. Biotechnologically expanded for clinical application.
Porcine Islet Cell Culture
Pancreatic islet cells from pigs cultured for xenotransplantation in diabetes treatment. Under HTS 3002.59.00.00 as other animal cell cultures for therapeutic, prophylactic uses. Addresses insulin-dependent diabetes.
iPSC-Derived Cardiomyocyte Cell Line
Induced pluripotent stem cell (iPSC)-derived cardiomyocytes grown in specialized media for cardiac repair therapies and drug toxicity testing. Classified under HTS 3002.59.00.00 as modified cell cultures for therapeutic uses, obtained through biotechnological reprogramming. These are used in clinical trials for heart disease treatments.
Primary Human Hepatocyte Cell Culture
Freshly isolated primary hepatocytes from human liver tissue, cultured for drug metabolism studies and liver failure therapies. This product is under HTS 3002.59.00.00 as other cell cultures prepared for therapeutic, prophylactic, or diagnostic uses. It supports hepatocyte transplantation and toxicology testing.
Murine T-Cell Hybridoma Culture
Hybridoma cell lines from mouse T-cells cultured for producing immunological products like cytokines in cancer immunotherapy. Falls under HTS 3002.59.00.00 as other animal cell cultures, whether modified, for therapeutic uses. These support monoclonal antibody production.